88149-49-9Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
-
Page/Page column 297-298, (2020/06/10)
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured (Formula A) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
Preparation method of 2,6-dibromo-4-trifluoromethoxyaniline
-
Paragraph 0012; 0022-0027, (2019/03/15)
The invention relates to a preparation method of 2,6-dibromo-4-trifluoromethoxyaniline, and belongs to the field of preparation of fine chemical engineering products. The preparation method of 2,6-dibromo-4-trifluoromethoxyaniline comprises the following
Preparation method of thifluzamide key intermediate, namely 2,6-dibromo-4-(trifluoromethoxy)aniline
-
Paragraph 0022-0033, (2017/08/29)
The invention discloses a preparation method of a thifluzamide key intermediate, namely 2,6-dibromo-4-(trifluoromethoxy)aniline. The method comprises the following operating steps: (1) adding water into a reaction bottle, dropwise adding concentrated sulf
Catalytic asymmetric pictet-spengler-type reaction for the synthesis of optically active indolo[3,4-cd][1]benzazepines
Cheng, Dao-Juan,Wu, Hai-Bian,Tian, Shi-Kai
supporting information; experimental part, p. 5636 - 5639 (2011/12/02)
A new strategy has been introduced to develop a catalytic asymmetric Pictet-Spengler-type reaction by replacing the aldehyde with an imine. A range of 4-(2-aminoaryl)indoles smoothly undergo the chiral phosphoric acid catalyzed asymmetric Pictet-Spengler-
